Lennar Corp
LEN
Adobe
ADBE
D.R. Horton
DHI
Oracle
ORCL
Apple
AAPL
US Stock MarketDetailed Quotes
IOBT IO Biotech
- 0.940
- +0.030+3.31%
Trading Dec 26 15:17 ET
61.93MMarket Cap-0.73P/E (TTM)
0.981High0.930Low238.03KVolume0.940Open0.910Pre Close227.46KTurnover0.86%Turnover RatioLossP/E (Static)65.88MShares2.09852wk High0.85P/B26.17MFloat Cap0.66052wk Low--Dividend TTM27.84MShs Float17.880Historical High--Div YieldTTM5.65%Amplitude0.660Historical Low0.955Avg Price1Lot Size
IO Biotech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.13%-20.81M | 7.01%-16.98M | -69.72%-24.93M | -20.10%-71.74M | -81.98%-22.8M | -19.79%-15.99M | -40.36%-18.26M | 29.52%-14.69M | -46.95%-59.73M | 34.90%-12.53M |
| Net income from continuing operations | -10.78%-24.02M | 2.32%-20.69M | -14.16%-19.46M | -20.47%-86.08M | -30.45%-26.18M | -38.19%-21.68M | -14.51%-21.18M | 0.93%-17.04M | -5.27%-71.46M | 5.81%-20.07M |
| Operating gains losses | -576.61%-1.63M | 1,000.00%90K | 279.07%462K | -154.62%-331K | 22.41%-405K | 293.10%342K | -103.51%-10K | -1,390.00%-258K | 59.25%-130K | -4,250.00%-522K |
| Depreciation and amortization | 5.67%205K | 14.44%214K | 21.26%211K | 40.00%756K | 5.79%201K | 63.03%194K | 1,600.00%187K | -20.91%174K | 26,900.00%540K | 9,400.00%190K |
| Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --87K | ---- |
| Change In working capital | 36.32%2.95M | 57.58%1.76M | -1,502.73%-7.72M | 39.84%5.86M | -66.83%2.03M | 910.49%2.16M | -70.89%1.12M | 110.00%550K | 640.21%4.19M | 470.14%6.13M |
| -Change in prepaid assets | 352.41%846K | -195.12%-760K | -210.21%-2.08M | -65.75%1.57M | -237.11%-1.31M | -91.71%187K | -68.10%799K | 266.23%1.89M | 156.59%4.58M | 125.08%954K |
| -Change in payables and accrued expense | 10.45%2.32M | 475.22%2.67M | -1,190.63%-4.69M | 2,514.78%4.9M | -39.98%2.71M | 184.72%2.1M | -77.29%464K | 91.52%-363K | -102.77%-203K | -8.10%4.51M |
| -Change in other current assets | -318.18%-48K | 135.71%5K | 0.00%-792K | 90.91%-4K | 8.94%780K | 0.00%22K | 98.19%-14K | -8,700.00%-792K | -76.00%-44K | --716K |
| -Change in other current liabilities | -15.60%-163K | -17.16%-157K | 16.22%-155K | -334.53%-604K | -200.00%-144K | -98.59%-141K | -343.64%-134K | -146.67%-185K | ---139K | ---48K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.13%-20.81M | 7.01%-16.98M | -69.72%-24.93M | -20.10%-71.74M | -81.98%-22.8M | -19.79%-15.99M | -40.36%-18.26M | 29.52%-14.69M | -46.95%-59.73M | 34.90%-12.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 58.33%-10K | 69.23%-12K | 92.57%-11K | 53.19%-323K | 67.91%-112K | 79.66%-24K | 63.55%-39K | -27.59%-148K | -350.98%-690K | -132.67%-349K |
| Net PPE purchase and sale | 58.33%-10K | 69.23%-12K | 92.57%-11K | 53.19%-323K | 67.91%-112K | 79.66%-24K | 63.55%-39K | -27.59%-148K | -350.98%-690K | -132.67%-349K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 58.33%-10K | 69.23%-12K | 92.57%-11K | 53.19%-323K | 67.91%-112K | 79.66%-24K | 63.55%-39K | -27.59%-148K | -350.98%-690K | -132.67%-349K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 71.86M | -10K | 0 | 0 | ||||||
| Net common stock issuance | ---- | ---- | ---- | --75.06M | --0 | ---- | ---- | ---- | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---3.2M | ---10K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --71.86M | ---10K | --71.87M | --0 | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -8.47%101.02M | -8.19%118.25M | 0.42%143.46M | -32.55%142.86M | 9.46%165.77M | -35.23%110.36M | -31.55%128.8M | -32.55%142.86M | 6,120.23%211.8M | 232.99%151.44M |
| Current changes in cash | -137.27%-20.82M | 7.14%-16.99M | -68.10%-24.94M | 99.67%-200K | -78.00%-22.92M | 514.79%55.86M | -39.51%-18.3M | 29.21%-14.84M | -128.48%-60.42M | -107.66%-12.88M |
| Effect of exchange rate changes | 156.89%256K | -83.97%-241K | -134.58%-268K | 109.42%803K | -85.83%609K | 91.80%-450K | 97.19%-131K | 129.06%775K | -126.77%-8.52M | 334.68%4.3M |
| End cash Position | -51.47%80.45M | -8.47%101.02M | -8.19%118.25M | 0.42%143.46M | 0.42%143.46M | 9.46%165.77M | -35.23%110.36M | -31.55%128.8M | -32.55%142.86M | -32.55%142.86M |
| Free cash flow | -30.00%-20.82M | 7.14%-16.99M | -68.10%-24.94M | -19.27%-72.06M | -77.92%-22.91M | -18.92%-16.01M | -39.51%-18.3M | 29.21%-14.84M | -48.09%-60.42M | 33.60%-12.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.